Danger signals and skin sensitization
Identifieur interne : 004272 ( Istex/Corpus ); précédent : 004271; suivant : 004273Danger signals and skin sensitization
Auteurs : I. Kimber ; M. Cumberbatch ; R. J. Dearman ; C. E. M. GriffithsSource :
- British Journal of Dermatology [ 0007-0963 ] ; 2002-09.
Url:
DOI: 10.1046/j.1365-2133.2002.48776.x
Links to Exploration step
ISTEX:8D83CB0E5B4E7E46ABB16B639A65C513623A8340Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Danger signals and skin sensitization</title>
<author><name sortKey="Kimber, I" sort="Kimber, I" uniqKey="Kimber I" first="I." last="Kimber">I. Kimber</name>
<affiliation><mods:affiliation>Syngenta Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire SK10 4TJ, U.K.</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Cumberbatch, M" sort="Cumberbatch, M" uniqKey="Cumberbatch M" first="M." last="Cumberbatch">M. Cumberbatch</name>
<affiliation><mods:affiliation>Syngenta Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire SK10 4TJ, U.K.</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Dearman, R J" sort="Dearman, R J" uniqKey="Dearman R" first="R. J." last="Dearman">R. J. Dearman</name>
<affiliation><mods:affiliation>Syngenta Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire SK10 4TJ, U.K.</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Griffiths, C E M" sort="Griffiths, C E M" uniqKey="Griffiths C" first="C. E. M." last="Griffiths">C. E. M. Griffiths</name>
<affiliation><mods:affiliation>The Dermatology Centre, University of Manchester, Manchester, U.K. Correspondence: I. Kimber E‐mail: ian.kimber@syngenta.com</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:8D83CB0E5B4E7E46ABB16B639A65C513623A8340</idno>
<date when="2002" year="2002">2002</date>
<idno type="doi">10.1046/j.1365-2133.2002.48776.x</idno>
<idno type="url">https://api.istex.fr/document/8D83CB0E5B4E7E46ABB16B639A65C513623A8340/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">004272</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">004272</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main">Danger signals and skin sensitization</title>
<author><name sortKey="Kimber, I" sort="Kimber, I" uniqKey="Kimber I" first="I." last="Kimber">I. Kimber</name>
<affiliation><mods:affiliation>Syngenta Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire SK10 4TJ, U.K.</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Cumberbatch, M" sort="Cumberbatch, M" uniqKey="Cumberbatch M" first="M." last="Cumberbatch">M. Cumberbatch</name>
<affiliation><mods:affiliation>Syngenta Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire SK10 4TJ, U.K.</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Dearman, R J" sort="Dearman, R J" uniqKey="Dearman R" first="R. J." last="Dearman">R. J. Dearman</name>
<affiliation><mods:affiliation>Syngenta Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire SK10 4TJ, U.K.</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Griffiths, C E M" sort="Griffiths, C E M" uniqKey="Griffiths C" first="C. E. M." last="Griffiths">C. E. M. Griffiths</name>
<affiliation><mods:affiliation>The Dermatology Centre, University of Manchester, Manchester, U.K. Correspondence: I. Kimber E‐mail: ian.kimber@syngenta.com</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">British Journal of Dermatology</title>
<title level="j" type="alt">BRITISH JOURNAL OF DERMATOLOGY</title>
<idno type="ISSN">0007-0963</idno>
<idno type="eISSN">1365-2133</idno>
<imprint><biblScope unit="vol">147</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="613">613</biblScope>
<biblScope unit="page" to="613">613</biblScope>
<biblScope unit="page-count">2</biblScope>
<publisher>Blackwell Science Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2002-09">2002-09</date>
</imprint>
<idno type="ISSN">0007-0963</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0007-0963</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
</TEI>
<istex><corpusName>wiley</corpusName>
<keywords><teeft><json:string>dermatology</json:string>
<json:string>dermatol</json:string>
<json:string>dermatologist</json:string>
<json:string>psoriasis</json:string>
<json:string>tumour</json:string>
<json:string>cutaneous</json:string>
<json:string>british journal</json:string>
<json:string>imiquimod</json:string>
<json:string>british association</json:string>
<json:string>ichthyosis</json:string>
<json:string>tacrolimus</json:string>
<json:string>teledermatology</json:string>
<json:string>apoptosis</json:string>
<json:string>erosive</json:string>
<json:string>fusarium</json:string>
<json:string>platelet</json:string>
<json:string>woolly hair</json:string>
<json:string>thrombocytopenia</json:string>
<json:string>cytokine</json:string>
<json:string>atrophoderma</json:string>
<json:string>nimesulide</json:string>
<json:string>follicular atrophoderma</json:string>
<json:string>receptor</json:string>
<json:string>immune</json:string>
<json:string>multifocal</json:string>
<json:string>basiliximab</json:string>
<json:string>osteomyelitis</json:string>
<json:string>node</json:string>
<json:string>basal</json:string>
<json:string>montelukast</json:string>
<json:string>platelet count</json:string>
<json:string>hypotrichosis</json:string>
<json:string>sarcoma</json:string>
<json:string>crmo</json:string>
<json:string>metastasis</json:string>
<json:string>cyclosporin</json:string>
<json:string>ndings</json:string>
<json:string>immunol</json:string>
<json:string>pustular</json:string>
<json:string>onychomycosis</json:string>
<json:string>sensitization</json:string>
<json:string>melanoma</json:string>
<json:string>dermatitis</json:string>
<json:string>vulval</json:string>
<json:string>syndrome</json:string>
<json:string>lichen</json:string>
<json:string>angiotensin</json:string>
<json:string>malignant</json:string>
<json:string>topical tacrolimus</json:string>
<json:string>multifocal osteomyelitis</json:string>
<json:string>paclitaxel</json:string>
<json:string>clin</json:string>
<json:string>metastatic</json:string>
<json:string>bowel</json:string>
<json:string>epidermal</json:string>
<json:string>danger signals</json:string>
<json:string>sartans</json:string>
<json:string>allergen</json:string>
<json:string>leukaemia</json:string>
<json:string>precursor</json:string>
<json:string>planus</json:string>
<json:string>pustuloderma</json:string>
<json:string>langerhans</json:string>
<json:string>topical treatment</json:string>
<json:string>docetaxel</json:string>
<json:string>granulocytic sarcoma</json:string>
<json:string>arch dermatol</json:string>
<json:string>follicular</json:string>
<json:string>lymphoma</json:string>
<json:string>genodermatosis</json:string>
<json:string>palmoplantar</json:string>
<json:string>mechanical injury</json:string>
<json:string>sartan</json:string>
<json:string>keratinocytes</json:string>
<json:string>solani</json:string>
<json:string>toenail</json:string>
<json:string>pustule</json:string>
<json:string>tunel</json:string>
<json:string>skin sensitization</json:string>
<json:string>bystander</json:string>
<json:string>lesion</json:string>
<json:string>carcinoma</json:string>
<json:string>acad dermatol</json:string>
<json:string>myeloid</json:string>
<json:string>topical</json:string>
<json:string>granulocytic</json:string>
<json:string>sartan treatment</json:string>
<json:string>great toenails</json:string>
<json:string>patch testing</json:string>
<json:string>topical imiquimod</json:string>
<json:string>pyoderma gangrenosum</json:string>
<json:string>malignant melanoma</json:string>
<json:string>contact dermatitis</json:string>
<json:string>skin lesions</json:string>
<json:string>basal cell carcinoma</json:string>
<json:string>immune system</json:string>
<json:string>drug reaction</json:string>
<json:string>eosin staining</json:string>
<json:string>lymph nodes</json:string>
<json:string>palmoplantar keratoderma</json:string>
<json:string>congenital ichthyosis</json:string>
<json:string>skin biopsy</json:string>
<json:string>topical imiquimod treatment</json:string>
<json:string>cutaneous lesions</json:string>
<json:string>university hospital</json:string>
<json:string>danger hypothesis</json:string>
<json:string>successful treatment</json:string>
<json:string>allergic contact dermatitis</json:string>
<json:string>santa cruz biotechnology</json:string>
<json:string>biopsy</json:string>
<json:string>lymph</json:string>
<json:string>congenital</json:string>
<json:string>trauma</json:string>
<json:string>localized</json:string>
<json:string>taipei</json:string>
<json:string>chemical allergens</json:string>
<json:string>british skin foundation</json:string>
<json:string>functional subpopulations</json:string>
<json:string>tumour necrosis</json:string>
<json:string>langerhans cells</json:string>
<json:string>pediatr dermatol</json:string>
<json:string>wire brush</json:string>
<json:string>clinicopathologic study</json:string>
<json:string>teledermatology service</json:string>
<json:string>pustular psoriasis</json:string>
<json:string>bowel disease</json:string>
<json:string>creatinine clearance</json:string>
<json:string>inheritance pattern</json:string>
<json:string>topical application</json:string>
<json:string>positive staining</json:string>
<json:string>skin metastases</json:string>
<json:string>tumour cells</json:string>
<json:string>ichthyotic skin</json:string>
<json:string>toxic pustuloderma</json:string>
<json:string>family history</json:string>
<json:string>ichthyosis vulgaris</json:string>
<json:string>second report</json:string>
<json:string>nail unit</json:string>
<json:string>oral prednisolone</json:string>
<json:string>immune response</json:string>
<json:string>candesartan cilexetil</json:string>
<json:string>woolly</json:string>
<json:string>granulocytic sarcomas</json:string>
<json:string>regional lymph nodes</json:string>
<json:string>host resistance</json:string>
<json:string>foreign antigen</json:string>
<json:string>fusarium oxysporum</json:string>
<json:string>skin irritation</json:string>
<json:string>danger model</json:string>
<json:string>other cytokines</json:string>
<json:string>chemical allergen</json:string>
<json:string>cytotoxic molecules</json:string>
<json:string>viral infection</json:string>
<json:string>large part</json:string>
<json:string>fusarium onychomycosis</json:string>
<json:string>other signals</json:string>
<json:string>cytokine signals</json:string>
<json:string>references figure</json:string>
<json:string>myeloid precursor</json:string>
<json:string>langerhans cell migration</json:string>
<json:string>bone marrow</json:string>
<json:string>lactophenol cotton</json:string>
<json:string>irregular diameter</json:string>
<json:string>important role</json:string>
<json:string>apoptotic cells</json:string>
<json:string>tissue remodelling</json:string>
<json:string>cell precursor</json:string>
<json:string>local wound therapy</json:string>
<json:string>tissue staining</json:string>
<json:string>terminal deoxynucleotidyl deoxyuridine triphosphate nick</json:string>
<json:string>fungal melanonychia</json:string>
<json:string>rare case</json:string>
<json:string>western blot analysis</json:string>
<json:string>wound edge</json:string>
<json:string>tunel staining</json:string>
<json:string>nuclear accumulation</json:string>
<json:string>gold particles</json:string>
<json:string>positive tunel staining</json:string>
<json:string>mouse skin</json:string>
<json:string>intralesional corticosteroids</json:string>
<json:string>fatal hyalohyphomycosis</json:string>
<json:string>oral sulphasalazine</json:string>
<json:string>fusarium solani</json:string>
<json:string>initial presentation</json:string>
<json:string>therapeutic class</json:string>
<json:string>myeloid cell markers</json:string>
<json:string>transient myalgia</json:string>
<json:string>montelukast therapy</json:string>
<json:string>skin biopsies</json:string>
<json:string>asthmatic patients</json:string>
<json:string>skin involvement</json:string>
<json:string>lower extremities</json:string>
<json:string>systemic vasculitis</json:string>
<json:string>palmoplantar pustular psoriasis</json:string>
<json:string>dramatic response</json:string>
<json:string>wooly hair</json:string>
<json:string>nailfold capillaroscopy</json:string>
<json:string>normal range</json:string>
<json:string>clinical features</json:string>
<json:string>autosomal recessive inheritance</json:string>
<json:string>cardiac abnormalities</json:string>
<json:string>basal cell carcinomas</json:string>
<json:string>case report</json:string>
<json:string>leukaemia cutis</json:string>
<json:string>flow cytometric analysis</json:string>
<json:string>upper right</json:string>
<json:string>ultrasound imaging</json:string>
<json:string>metastatic skin area</json:string>
<json:string>extensor surfaces</json:string>
<json:string>monoclonal antibody</json:string>
<json:string>correspondence figure</json:string>
<json:string>happle syndrome</json:string>
<json:string>cell markers</json:string>
<json:string>differential diagnosis</json:string>
<json:string>focal hypogranulosis</json:string>
<json:string>clinical investigation</json:string>
<json:string>chain gene</json:string>
<json:string>immunohistochemical staining</json:string>
<json:string>drug reactions</json:string>
<json:string>drug intake</json:string>
<json:string>haematopoietic neoplasms</json:string>
<json:string>erosive vulvovaginal lichen planus</json:string>
<json:string>scalp hair</json:string>
<json:string>adaptive immunity</json:string>
<json:string>skin disorders</json:string>
<json:string>major improvement</json:string>
<json:string>vulval mucosa</json:string>
<json:string>topical cyclosporin</json:string>
<json:string>drug compatibility</json:string>
<json:string>natural killer</json:string>
<json:string>severe thrombocytopenia</json:string>
<json:string>full blood cell count</json:string>
<json:string>blood transfusion</json:string>
<json:string>lower right</json:string>
<json:string>central role</json:string>
<json:string>time course</json:string>
<json:string>neural cell adhesion molecule</json:string>
<json:string>oral terbinafine</json:string>
<json:string>professional radiodermatitis</json:string>
<json:string>pigmentation disorders</json:string>
<json:string>commonest skin cancer</json:string>
<json:string>chronic trauma</json:string>
<json:string>book reviews</json:string>
<json:string>oral prednisone</json:string>
<json:string>dermatol surg oncol</json:string>
<json:string>bone pain</json:string>
<json:string>introductory section</json:string>
<json:string>book deals</json:string>
<json:string>cell death</json:string>
<json:string>nail</json:string>
</teeft>
</keywords>
<author><json:item><name>I. Kimber</name>
<affiliations><json:string>Syngenta Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire SK10 4TJ, U.K.</json:string>
</affiliations>
</json:item>
<json:item><name>M. Cumberbatch</name>
<affiliations><json:string>Syngenta Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire SK10 4TJ, U.K.</json:string>
</affiliations>
</json:item>
<json:item><name>R.J. Dearman</name>
<affiliations><json:string>Syngenta Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire SK10 4TJ, U.K.</json:string>
</affiliations>
</json:item>
<json:item><name>C.E.M. Griffiths</name>
<affiliations><json:string>The Dermatology Centre, University of Manchester, Manchester, U.K. Correspondence: I. Kimber E‐mail: ian.kimber@syngenta.com</json:string>
</affiliations>
</json:item>
</author>
<articleId><json:string>BJD4877_6</json:string>
</articleId>
<language><json:string>eng</json:string>
</language>
<originalGenre><json:string>letter</json:string>
</originalGenre>
<qualityIndicators><score>5.012</score>
<pdfVersion>1.3</pdfVersion>
<pdfPageSize>595 x 782 pts</pdfPageSize>
<refBibsNative>true</refBibsNative>
<abstractCharCount>0</abstractCharCount>
<pdfWordCount>15451</pdfWordCount>
<pdfCharCount>100973</pdfCharCount>
<pdfPageCount>28</pdfPageCount>
<abstractWordCount>1</abstractWordCount>
</qualityIndicators>
<title>Danger signals and skin sensitization</title>
<genre><json:string>review-article</json:string>
</genre>
<host><title>British Journal of Dermatology</title>
<language><json:string>unknown</json:string>
</language>
<doi><json:string>10.1111/(ISSN)1365-2133</json:string>
</doi>
<issn><json:string>0007-0963</json:string>
</issn>
<eissn><json:string>1365-2133</json:string>
</eissn>
<publisherId><json:string>BJD</json:string>
</publisherId>
<volume>147</volume>
<issue>3</issue>
<pages><first>613</first>
<last>613</last>
<total>2</total>
</pages>
<genre><json:string>journal</json:string>
</genre>
</host>
<categories><wos><json:string>science</json:string>
<json:string>dermatology</json:string>
</wos>
<scienceMetrix><json:string>health sciences</json:string>
<json:string>clinical medicine</json:string>
<json:string>dermatology & venereal diseases</json:string>
</scienceMetrix>
</categories>
<publicationDate>2002</publicationDate>
<copyrightDate>2002</copyrightDate>
<doi><json:string>10.1046/j.1365-2133.2002.48776.x</json:string>
</doi>
<id>8D83CB0E5B4E7E46ABB16B639A65C513623A8340</id>
<score>1</score>
<fulltext><json:item><extension>pdf</extension>
<original>true</original>
<mimetype>application/pdf</mimetype>
<uri>https://api.istex.fr/document/8D83CB0E5B4E7E46ABB16B639A65C513623A8340/fulltext/pdf</uri>
</json:item>
<json:item><extension>zip</extension>
<original>false</original>
<mimetype>application/zip</mimetype>
<uri>https://api.istex.fr/document/8D83CB0E5B4E7E46ABB16B639A65C513623A8340/fulltext/zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/document/8D83CB0E5B4E7E46ABB16B639A65C513623A8340/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main">Danger signals and skin sensitization</title>
</titleStmt>
<publicationStmt><publisher>Blackwell Science Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2002-09"></date>
</publicationStmt>
<notesStmt><note type="content-type" subtype="review-article" source="letter" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-L5L7X3NF-P">review-article</note>
<note type="publication-type" subtype="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note>
</notesStmt>
<sourceDesc><biblStruct type="review-article"><analytic><title level="a" type="main">Danger signals and skin sensitization</title>
<title level="a" type="short">CORRESPONDENCE</title>
<author xml:id="author-0000"><persName><forename type="first">I.</forename>
<surname>Kimber</surname>
</persName>
<affiliation>Syngenta Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire SK10 4TJ, U.K.</affiliation>
</author>
<author xml:id="author-0001"><persName><forename type="first">M.</forename>
<surname>Cumberbatch</surname>
</persName>
<affiliation>Syngenta Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire SK10 4TJ, U.K.</affiliation>
</author>
<author xml:id="author-0002"><persName><forename type="first">R.J.</forename>
<surname>Dearman</surname>
</persName>
<affiliation>Syngenta Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire SK10 4TJ, U.K.</affiliation>
</author>
<author xml:id="author-0003"><persName><forename type="first">C.E.M.</forename>
<surname>Griffiths</surname>
</persName>
<affiliation>
The Dermatology Centre, University of Manchester, Manchester, U.K. Correspondence: I. Kimber E‐mail: </affiliation>
<email>ian.kimber@syngenta.com</email>
</author>
<idno type="istex">8D83CB0E5B4E7E46ABB16B639A65C513623A8340</idno>
<idno type="DOI">10.1046/j.1365-2133.2002.48776.x</idno>
<idno type="unit">BJD4877_6</idno>
<idno type="toTypesetVersion">file:BJD.BJD4877_6.pdf</idno>
</analytic>
<monogr><title level="j" type="main">British Journal of Dermatology</title>
<title level="j" type="alt">BRITISH JOURNAL OF DERMATOLOGY</title>
<idno type="pISSN">0007-0963</idno>
<idno type="eISSN">1365-2133</idno>
<idno type="book-DOI">10.1111/(ISSN)1365-2133</idno>
<idno type="book-part-DOI">10.1111/bjd.2002.147.issue-3</idno>
<idno type="product">BJD</idno>
<idno type="publisherDivision">ST</idno>
<imprint><biblScope unit="vol">147</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="613">613</biblScope>
<biblScope unit="page" to="613">613</biblScope>
<biblScope unit="page-count">2</biblScope>
<publisher>Blackwell Science Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2002-09"></date>
</imprint>
</monogr>
</biblStruct>
</sourceDesc>
</fileDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item><extension>txt</extension>
<original>false</original>
<mimetype>text/plain</mimetype>
<uri>https://api.istex.fr/document/8D83CB0E5B4E7E46ABB16B639A65C513623A8340/fulltext/txt</uri>
</json:item>
</fulltext>
<metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration>
<istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Blackwell Science Ltd</publisherName>
<publisherLoc>Oxford, UK</publisherLoc>
</publisherInfo>
<doi origin="wiley" registered="yes">10.1111/(ISSN)1365-2133</doi>
<issn type="print">0007-0963</issn>
<issn type="electronic">1365-2133</issn>
<idGroup><id type="product" value="BJD"></id>
<id type="publisherDivision" value="ST"></id>
</idGroup>
<titleGroup><title type="main" sort="BRITISH JOURNAL OF DERMATOLOGY">British Journal of Dermatology</title>
</titleGroup>
</publicationMeta>
<publicationMeta level="part" position="09003"><doi origin="wiley">10.1111/bjd.2002.147.issue-3</doi>
<numberingGroup><numbering type="journalVolume" number="147">147</numbering>
<numbering type="journalIssue" number="3">3</numbering>
</numberingGroup>
<coverDate startDate="2002-09">September 2002</coverDate>
</publicationMeta>
<publicationMeta level="unit" type="letter" position="0061300" status="forIssue"><doi origin="wiley">10.1046/j.1365-2133.2002.48776.x</doi>
<idGroup><id type="unit" value="BJD4877_6"></id>
</idGroup>
<countGroup><count type="pageTotal" number="2"></count>
</countGroup>
<titleGroup><title type="tocHeading1">Correspondence</title>
</titleGroup>
<eventGroup><event type="firstOnline" date="2002-10-04"></event>
<event type="publishedOnlineFinalForm" date="2002-10-04"></event>
<event type="xmlConverted" agent="Converter:BPG_TO_WML3G version:2.3.6 mode:FullText source:HeaderRef result:HeaderRef" date="2010-04-29"></event>
<event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:4.0.1" date="2014-03-15"></event>
<event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-15"></event>
</eventGroup>
<numberingGroup><numbering type="pageFirst" number="613">613</numbering>
<numbering type="pageLast" number="613">613</numbering>
</numberingGroup>
<linkGroup><link type="toTypesetVersion" href="file:BJD.BJD4877_6.pdf"></link>
</linkGroup>
</publicationMeta>
<contentMeta><countGroup><count type="figureTotal" number="0"></count>
<count type="tableTotal" number="0"></count>
<count type="formulaTotal" number="0"></count>
<count type="referenceTotal" number="13"></count>
<count type="wordTotal" number="1777"></count>
<count type="linksPubMed" number="0"></count>
<count type="linksCrossRef" number="0"></count>
</countGroup>
<titleGroup><title type="main">Danger signals and skin sensitization</title>
<title type="shortAuthors">CORRESPONDENCE</title>
<title type="short">CORRESPONDENCE</title>
</titleGroup>
<creators><creator creatorRole="author" xml:id="cr1" affiliationRef="#a1-6"><personName><givenNames>I.</givenNames>
<familyName>Kimber</familyName>
</personName>
</creator>
<creator creatorRole="author" xml:id="cr2" affiliationRef="#a1-6"><personName><givenNames>M.</givenNames>
<familyName>Cumberbatch</familyName>
</personName>
</creator>
<creator creatorRole="author" xml:id="cr3" affiliationRef="#a1-6"><personName><givenNames>R.J.</givenNames>
<familyName>Dearman</familyName>
</personName>
</creator>
<creator creatorRole="author" xml:id="cr4" affiliationRef="#a2-6"><personName><givenNames>C.E.M.</givenNames>
<familyName>Griffiths</familyName>
</personName>
</creator>
</creators>
<affiliationGroup><affiliation xml:id="a1-6"><unparsedAffiliation>Syngenta Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire SK10 4TJ, U.K.</unparsedAffiliation>
</affiliation>
<affiliation xml:id="a2-6"><unparsedAffiliation>
The Dermatology Centre, University of Manchester, Manchester, U.K. Correspondence: I. Kimber E‐mail: <email>ian.kimber@syngenta.com</email>
</unparsedAffiliation>
</affiliation>
</affiliationGroup>
</contentMeta>
</header>
</component>
</istex:document>
</istex:metadataXml>
<mods version="3.6"><titleInfo lang="en"><title>Danger signals and skin sensitization</title>
</titleInfo>
<titleInfo type="abbreviated" lang="en"><title>CORRESPONDENCE</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA" lang="en"><title>Danger signals and skin sensitization</title>
</titleInfo>
<name type="personal"><namePart type="given">I.</namePart>
<namePart type="family">Kimber</namePart>
<affiliation>Syngenta Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire SK10 4TJ, U.K.</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">M.</namePart>
<namePart type="family">Cumberbatch</namePart>
<affiliation>Syngenta Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire SK10 4TJ, U.K.</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">R.J.</namePart>
<namePart type="family">Dearman</namePart>
<affiliation>Syngenta Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire SK10 4TJ, U.K.</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">C.E.M.</namePart>
<namePart type="family">Griffiths</namePart>
<affiliation>The Dermatology Centre, University of Manchester, Manchester, U.K. Correspondence: I. Kimber E‐mail: ian.kimber@syngenta.com</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="review-article" displayLabel="letter"></genre>
<originInfo><publisher>Blackwell Science Ltd</publisher>
<place><placeTerm type="text">Oxford, UK</placeTerm>
</place>
<dateIssued encoding="w3cdtf">2002-09</dateIssued>
<copyrightDate encoding="w3cdtf">2002</copyrightDate>
</originInfo>
<language><languageTerm type="code" authority="rfc3066">en</languageTerm>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<physicalDescription><internetMediaType>text/html</internetMediaType>
<extent unit="references">13</extent>
<extent unit="words">1777</extent>
</physicalDescription>
<relatedItem type="host"><titleInfo><title>British Journal of Dermatology</title>
</titleInfo>
<genre type="journal">journal</genre>
<identifier type="ISSN">0007-0963</identifier>
<identifier type="eISSN">1365-2133</identifier>
<identifier type="DOI">10.1111/(ISSN)1365-2133</identifier>
<identifier type="PublisherID">BJD</identifier>
<part><date>2002</date>
<detail type="volume"><caption>vol.</caption>
<number>147</number>
</detail>
<detail type="issue"><caption>no.</caption>
<number>3</number>
</detail>
<extent unit="pages"><start>613</start>
<end>613</end>
<total>2</total>
</extent>
</part>
</relatedItem>
<identifier type="istex">8D83CB0E5B4E7E46ABB16B639A65C513623A8340</identifier>
<identifier type="DOI">10.1046/j.1365-2133.2002.48776.x</identifier>
<identifier type="ArticleID">BJD4877_6</identifier>
<recordInfo><recordContentSource>WILEY</recordContentSource>
<recordOrigin>Blackwell Science Ltd</recordOrigin>
</recordInfo>
</mods>
</metadata>
<serie></serie>
</istex>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004272 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 004272 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Istex |étape= Corpus |type= RBID |clé= ISTEX:8D83CB0E5B4E7E46ABB16B639A65C513623A8340 |texte= Danger signals and skin sensitization }}
![]() | This area was generated with Dilib version V0.6.31. | ![]() |